Can DNA methylation be a molecular marker for eradication of Helicobactor pylori in MALT lymphoma?

Journal of Gastroenterology

Volumn 37, Issue 1, 2002, Pages 73-74

  Toyota, Minoru ^a   Itoh, Fumio ^a   Imai, Kohzoh ^a  

^a SAPPORO MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; CYCLIN DEPENDENT KINASE INHIBITOR; DNA; MOLECULAR MARKER;

B CELL LYMPHOMA; CHROMOSOME 14Q; CHROMOSOME 1P; CHROMOSOME TRANSLOCATION 1; CHROMOSOME TRANSLOCATION 14; CLINICAL ARTICLE; CLINICAL FEATURE; CPG ISLAND; DIAGNOSTIC VALUE; DIGESTIVE SYSTEM CANCER; DNA METHYLATION; EDITORIAL; GENE INACTIVATION; GENE SILENCING; GENE TARGETING; HELICOBACTER INFECTION; HUMAN; MOLECULAR BIOLOGY; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; PATHOGENESIS; POINT MUTATION; PRIORITY JOURNAL; PROMOTER REGION; STOMACH MUCOSA; TUMOR SUPPRESSOR GENE;

BIOLOGICAL MARKERS; DNA METHYLATION; GENES, P16; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; LYMPHOMA, MUCOSA-ASSOCIATED LYMPHOID TISSUE; REMISSION INDUCTION; STOMACH NEOPLASMS;

EID: 0036166606     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s535-002-8138-1     Document Type: Editorial

References (15)

1. Hypermethylation of a 5′ CpG island of p16 is a frequent event in non-Hodgkin's lymphoma
2. Regression of low-grade gastric mucosa-associated lymphoid tissue lymphoma after eradication of Helicobactor pylori: Possible association with p16 hypermethylation
3. Deletion analysis of the p16 tumor suppressor gene in gastrointestinal mucosa-associated lymphoid tissue lymphomas
4. Bcl10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types
5. Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer
6. CpG island methylator phenotype in colorectal cancer
7. Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype
8. Hypermethylation of multiple genes in pancreatic adenocarcinoma
9. Hypermethylation of p15/ink4b/MTS2 gene is differentially implicated among non-Hodgkin's lymphomas
10. Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification
11. Risk of developing pancreatic cancer in families with familial atypical multiple mole melanoma associated with a specific 19 deletion of p16 (p16-Leiden)
12. Germline p16 mutations in familial melanoma
13. Hypermethylation can selectively silence individual p16ink4A alleles in neoplasia
14. Hypermethylation of the CDKN2/p16 promoter during neoplastic progression in Barrett's esophagus
15. Accelerated age-related CpG island methylation in ulcerative colitis